I am not able to attend.
My question is: "In relation to the intellectual property asset value that ACL places on the VAST and HyAct platforms"
1. What is the value (Clearly off balance sheet) attributed to these assets in the opinions of the board?
2. Is part of the Life Sciences assignment to place a value on these assets?
3. What is the remaining patent protection periods of these?
Email From Tracie Ramsdale, page-9
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable